Foralumab — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09 (month) in 26d
ESTIMATED |
READOUT
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosi
Phase 2 · Secondary Progressive Multiple Sclerosis |
TLSA Tiziana Life Sciences Ltd | Foralumab |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|